Loading…
Matrix metalloproteinases in peripheral vascular disease
Matrix metalloproteinases (MMPs) are extracellular matrix–modifying enzymes that are important in many physiologic and pathologic vascular processes. Dysregulation of MMP activity has been associated with common vascular diseases such as atherosclerotic plaque formation, abdominal aortic aneurysms,...
Saved in:
Published in: | Journal of vascular surgery 2007-04, Vol.45 (4), p.849-857 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c449t-8a4db12babe4f59afbab140fdcce21600cde15a82a21c7a7e72e84e9d2e29b2a3 |
---|---|
cites | cdi_FETCH-LOGICAL-c449t-8a4db12babe4f59afbab140fdcce21600cde15a82a21c7a7e72e84e9d2e29b2a3 |
container_end_page | 857 |
container_issue | 4 |
container_start_page | 849 |
container_title | Journal of vascular surgery |
container_volume | 45 |
creator | Hobeika, Mark J., MD Thompson, Robert W., MD Muhs, Bart E., MD Brooks, Peter C., PhD Gagne, Paul J., MD |
description | Matrix metalloproteinases (MMPs) are extracellular matrix–modifying enzymes that are important in many physiologic and pathologic vascular processes. Dysregulation of MMP activity has been associated with common vascular diseases such as atherosclerotic plaque formation, abdominal aortic aneurysms, and critical limb ischemia. For this reason, MMPs have become an important focus for basic science studies and clinical investigations by vascular biology researchers. This article reviews the recent literature, summarizing our current understanding of the role of MMPs in the pathogenesis of various peripheral vascular disease states. In addition, the importance of MMPs in the future diagnosis and treatment of peripheral vascular disease is discussed. |
doi_str_mv | 10.1016/j.jvs.2006.09.066 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70338410</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0741521406022531</els_id><sourcerecordid>70338410</sourcerecordid><originalsourceid>FETCH-LOGICAL-c449t-8a4db12babe4f59afbab140fdcce21600cde15a82a21c7a7e72e84e9d2e29b2a3</originalsourceid><addsrcrecordid>eNp9kU9r3DAQxUVJSTZpP0Avxafc7M7I8h9RKJTQNoWUHpqcxVgeU7laeyvZS_Pto2UXCjnkNAPz3mPmN0K8QygQsP4wFuM-FhKgLkAXUNevxAZBN3ndgj4TG2gU5pVEdSEuYxwBEKu2ORcX2JS6VYAb0f6gJbh_2ZYX8n7ehXlhN1HkmLkp23Fwu98cyGd7inb1FLLeRU7zN-L1QD7y21O9Eg9fv9zf3OZ3P799v_l8l1ul9JK3pPoOZUcdq6HSNKQOFQy9tSyxBrA9Y0WtJIm2oYYbya1i3UuWupNUXonrY25a7e_KcTFbFy17TxPPazQNlGWrEJIQj0Ib5hgDD2YX3JbCo0EwB1xmNAmXOeAyoE3ClTzvT-Frt-X-v-PEJwk-HgWcTtw7DiZax5Pl3gW2i-ln92L8p2du693kLPk__MhxnNcwJXYGTZQGzK_Dvw7vghqkrEosnwDWVZEz</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70338410</pqid></control><display><type>article</type><title>Matrix metalloproteinases in peripheral vascular disease</title><source>BACON - Elsevier - GLOBAL_SCIENCEDIRECT-OPENACCESS</source><creator>Hobeika, Mark J., MD ; Thompson, Robert W., MD ; Muhs, Bart E., MD ; Brooks, Peter C., PhD ; Gagne, Paul J., MD</creator><creatorcontrib>Hobeika, Mark J., MD ; Thompson, Robert W., MD ; Muhs, Bart E., MD ; Brooks, Peter C., PhD ; Gagne, Paul J., MD</creatorcontrib><description>Matrix metalloproteinases (MMPs) are extracellular matrix–modifying enzymes that are important in many physiologic and pathologic vascular processes. Dysregulation of MMP activity has been associated with common vascular diseases such as atherosclerotic plaque formation, abdominal aortic aneurysms, and critical limb ischemia. For this reason, MMPs have become an important focus for basic science studies and clinical investigations by vascular biology researchers. This article reviews the recent literature, summarizing our current understanding of the role of MMPs in the pathogenesis of various peripheral vascular disease states. In addition, the importance of MMPs in the future diagnosis and treatment of peripheral vascular disease is discussed.</description><identifier>ISSN: 0741-5214</identifier><identifier>EISSN: 1097-6809</identifier><identifier>DOI: 10.1016/j.jvs.2006.09.066</identifier><identifier>PMID: 17398401</identifier><language>eng</language><publisher>United States: Mosby, Inc</publisher><subject>Animals ; Aortic Aneurysm, Abdominal - drug therapy ; Aortic Aneurysm, Abdominal - enzymology ; Atherosclerosis - drug therapy ; Atherosclerosis - enzymology ; Biomarkers - metabolism ; Constriction, Pathologic - drug therapy ; Constriction, Pathologic - enzymology ; Constriction, Pathologic - surgery ; Enzyme Inhibitors - pharmacology ; Enzyme Inhibitors - therapeutic use ; Extremities - blood supply ; Humans ; Ischemia - drug therapy ; Ischemia - enzymology ; Matrix Metalloproteinases, Secreted - antagonists & inhibitors ; Matrix Metalloproteinases, Secreted - metabolism ; Peripheral Vascular Diseases - diagnosis ; Peripheral Vascular Diseases - drug therapy ; Peripheral Vascular Diseases - enzymology ; Recurrence ; Surgery ; Tissue Inhibitor of Metalloproteinases - metabolism ; Varicose Ulcer - drug therapy ; Varicose Ulcer - enzymology ; Varicose Veins - drug therapy ; Varicose Veins - enzymology ; Vascular Surgical Procedures - adverse effects ; Venous Thrombosis - drug therapy ; Venous Thrombosis - enzymology</subject><ispartof>Journal of vascular surgery, 2007-04, Vol.45 (4), p.849-857</ispartof><rights>The Society for Vascular Surgery</rights><rights>2007 The Society for Vascular Surgery</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c449t-8a4db12babe4f59afbab140fdcce21600cde15a82a21c7a7e72e84e9d2e29b2a3</citedby><cites>FETCH-LOGICAL-c449t-8a4db12babe4f59afbab140fdcce21600cde15a82a21c7a7e72e84e9d2e29b2a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17398401$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hobeika, Mark J., MD</creatorcontrib><creatorcontrib>Thompson, Robert W., MD</creatorcontrib><creatorcontrib>Muhs, Bart E., MD</creatorcontrib><creatorcontrib>Brooks, Peter C., PhD</creatorcontrib><creatorcontrib>Gagne, Paul J., MD</creatorcontrib><title>Matrix metalloproteinases in peripheral vascular disease</title><title>Journal of vascular surgery</title><addtitle>J Vasc Surg</addtitle><description>Matrix metalloproteinases (MMPs) are extracellular matrix–modifying enzymes that are important in many physiologic and pathologic vascular processes. Dysregulation of MMP activity has been associated with common vascular diseases such as atherosclerotic plaque formation, abdominal aortic aneurysms, and critical limb ischemia. For this reason, MMPs have become an important focus for basic science studies and clinical investigations by vascular biology researchers. This article reviews the recent literature, summarizing our current understanding of the role of MMPs in the pathogenesis of various peripheral vascular disease states. In addition, the importance of MMPs in the future diagnosis and treatment of peripheral vascular disease is discussed.</description><subject>Animals</subject><subject>Aortic Aneurysm, Abdominal - drug therapy</subject><subject>Aortic Aneurysm, Abdominal - enzymology</subject><subject>Atherosclerosis - drug therapy</subject><subject>Atherosclerosis - enzymology</subject><subject>Biomarkers - metabolism</subject><subject>Constriction, Pathologic - drug therapy</subject><subject>Constriction, Pathologic - enzymology</subject><subject>Constriction, Pathologic - surgery</subject><subject>Enzyme Inhibitors - pharmacology</subject><subject>Enzyme Inhibitors - therapeutic use</subject><subject>Extremities - blood supply</subject><subject>Humans</subject><subject>Ischemia - drug therapy</subject><subject>Ischemia - enzymology</subject><subject>Matrix Metalloproteinases, Secreted - antagonists & inhibitors</subject><subject>Matrix Metalloproteinases, Secreted - metabolism</subject><subject>Peripheral Vascular Diseases - diagnosis</subject><subject>Peripheral Vascular Diseases - drug therapy</subject><subject>Peripheral Vascular Diseases - enzymology</subject><subject>Recurrence</subject><subject>Surgery</subject><subject>Tissue Inhibitor of Metalloproteinases - metabolism</subject><subject>Varicose Ulcer - drug therapy</subject><subject>Varicose Ulcer - enzymology</subject><subject>Varicose Veins - drug therapy</subject><subject>Varicose Veins - enzymology</subject><subject>Vascular Surgical Procedures - adverse effects</subject><subject>Venous Thrombosis - drug therapy</subject><subject>Venous Thrombosis - enzymology</subject><issn>0741-5214</issn><issn>1097-6809</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><recordid>eNp9kU9r3DAQxUVJSTZpP0Avxafc7M7I8h9RKJTQNoWUHpqcxVgeU7laeyvZS_Pto2UXCjnkNAPz3mPmN0K8QygQsP4wFuM-FhKgLkAXUNevxAZBN3ndgj4TG2gU5pVEdSEuYxwBEKu2ORcX2JS6VYAb0f6gJbh_2ZYX8n7ehXlhN1HkmLkp23Fwu98cyGd7inb1FLLeRU7zN-L1QD7y21O9Eg9fv9zf3OZ3P799v_l8l1ul9JK3pPoOZUcdq6HSNKQOFQy9tSyxBrA9Y0WtJIm2oYYbya1i3UuWupNUXonrY25a7e_KcTFbFy17TxPPazQNlGWrEJIQj0Ib5hgDD2YX3JbCo0EwB1xmNAmXOeAyoE3ClTzvT-Frt-X-v-PEJwk-HgWcTtw7DiZax5Pl3gW2i-ln92L8p2du693kLPk__MhxnNcwJXYGTZQGzK_Dvw7vghqkrEosnwDWVZEz</recordid><startdate>20070401</startdate><enddate>20070401</enddate><creator>Hobeika, Mark J., MD</creator><creator>Thompson, Robert W., MD</creator><creator>Muhs, Bart E., MD</creator><creator>Brooks, Peter C., PhD</creator><creator>Gagne, Paul J., MD</creator><general>Mosby, Inc</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20070401</creationdate><title>Matrix metalloproteinases in peripheral vascular disease</title><author>Hobeika, Mark J., MD ; Thompson, Robert W., MD ; Muhs, Bart E., MD ; Brooks, Peter C., PhD ; Gagne, Paul J., MD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c449t-8a4db12babe4f59afbab140fdcce21600cde15a82a21c7a7e72e84e9d2e29b2a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Animals</topic><topic>Aortic Aneurysm, Abdominal - drug therapy</topic><topic>Aortic Aneurysm, Abdominal - enzymology</topic><topic>Atherosclerosis - drug therapy</topic><topic>Atherosclerosis - enzymology</topic><topic>Biomarkers - metabolism</topic><topic>Constriction, Pathologic - drug therapy</topic><topic>Constriction, Pathologic - enzymology</topic><topic>Constriction, Pathologic - surgery</topic><topic>Enzyme Inhibitors - pharmacology</topic><topic>Enzyme Inhibitors - therapeutic use</topic><topic>Extremities - blood supply</topic><topic>Humans</topic><topic>Ischemia - drug therapy</topic><topic>Ischemia - enzymology</topic><topic>Matrix Metalloproteinases, Secreted - antagonists & inhibitors</topic><topic>Matrix Metalloproteinases, Secreted - metabolism</topic><topic>Peripheral Vascular Diseases - diagnosis</topic><topic>Peripheral Vascular Diseases - drug therapy</topic><topic>Peripheral Vascular Diseases - enzymology</topic><topic>Recurrence</topic><topic>Surgery</topic><topic>Tissue Inhibitor of Metalloproteinases - metabolism</topic><topic>Varicose Ulcer - drug therapy</topic><topic>Varicose Ulcer - enzymology</topic><topic>Varicose Veins - drug therapy</topic><topic>Varicose Veins - enzymology</topic><topic>Vascular Surgical Procedures - adverse effects</topic><topic>Venous Thrombosis - drug therapy</topic><topic>Venous Thrombosis - enzymology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hobeika, Mark J., MD</creatorcontrib><creatorcontrib>Thompson, Robert W., MD</creatorcontrib><creatorcontrib>Muhs, Bart E., MD</creatorcontrib><creatorcontrib>Brooks, Peter C., PhD</creatorcontrib><creatorcontrib>Gagne, Paul J., MD</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of vascular surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hobeika, Mark J., MD</au><au>Thompson, Robert W., MD</au><au>Muhs, Bart E., MD</au><au>Brooks, Peter C., PhD</au><au>Gagne, Paul J., MD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Matrix metalloproteinases in peripheral vascular disease</atitle><jtitle>Journal of vascular surgery</jtitle><addtitle>J Vasc Surg</addtitle><date>2007-04-01</date><risdate>2007</risdate><volume>45</volume><issue>4</issue><spage>849</spage><epage>857</epage><pages>849-857</pages><issn>0741-5214</issn><eissn>1097-6809</eissn><abstract>Matrix metalloproteinases (MMPs) are extracellular matrix–modifying enzymes that are important in many physiologic and pathologic vascular processes. Dysregulation of MMP activity has been associated with common vascular diseases such as atherosclerotic plaque formation, abdominal aortic aneurysms, and critical limb ischemia. For this reason, MMPs have become an important focus for basic science studies and clinical investigations by vascular biology researchers. This article reviews the recent literature, summarizing our current understanding of the role of MMPs in the pathogenesis of various peripheral vascular disease states. In addition, the importance of MMPs in the future diagnosis and treatment of peripheral vascular disease is discussed.</abstract><cop>United States</cop><pub>Mosby, Inc</pub><pmid>17398401</pmid><doi>10.1016/j.jvs.2006.09.066</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0741-5214 |
ispartof | Journal of vascular surgery, 2007-04, Vol.45 (4), p.849-857 |
issn | 0741-5214 1097-6809 |
language | eng |
recordid | cdi_proquest_miscellaneous_70338410 |
source | BACON - Elsevier - GLOBAL_SCIENCEDIRECT-OPENACCESS |
subjects | Animals Aortic Aneurysm, Abdominal - drug therapy Aortic Aneurysm, Abdominal - enzymology Atherosclerosis - drug therapy Atherosclerosis - enzymology Biomarkers - metabolism Constriction, Pathologic - drug therapy Constriction, Pathologic - enzymology Constriction, Pathologic - surgery Enzyme Inhibitors - pharmacology Enzyme Inhibitors - therapeutic use Extremities - blood supply Humans Ischemia - drug therapy Ischemia - enzymology Matrix Metalloproteinases, Secreted - antagonists & inhibitors Matrix Metalloproteinases, Secreted - metabolism Peripheral Vascular Diseases - diagnosis Peripheral Vascular Diseases - drug therapy Peripheral Vascular Diseases - enzymology Recurrence Surgery Tissue Inhibitor of Metalloproteinases - metabolism Varicose Ulcer - drug therapy Varicose Ulcer - enzymology Varicose Veins - drug therapy Varicose Veins - enzymology Vascular Surgical Procedures - adverse effects Venous Thrombosis - drug therapy Venous Thrombosis - enzymology |
title | Matrix metalloproteinases in peripheral vascular disease |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T09%3A51%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Matrix%20metalloproteinases%20in%20peripheral%20vascular%20disease&rft.jtitle=Journal%20of%20vascular%20surgery&rft.au=Hobeika,%20Mark%20J.,%20MD&rft.date=2007-04-01&rft.volume=45&rft.issue=4&rft.spage=849&rft.epage=857&rft.pages=849-857&rft.issn=0741-5214&rft.eissn=1097-6809&rft_id=info:doi/10.1016/j.jvs.2006.09.066&rft_dat=%3Cproquest_cross%3E70338410%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c449t-8a4db12babe4f59afbab140fdcce21600cde15a82a21c7a7e72e84e9d2e29b2a3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=70338410&rft_id=info:pmid/17398401&rfr_iscdi=true |